Indivior (INDV) shares tick up 11.59% to 254.2p as the company sees boosted sales 

Indivior, a medical developer of opioid addiction treatment, said it is making plans to diversify the business by exploring a secondary listing in the United States, its biggest market to date.

In its final year results published today, the British company forecasted stronger sales growth for SUBLOCADE and PERSERIS in the second half of 2022 compared to the year’s first half. The company’s treatments are designed to target opioid use disorder and schizophrenia.

Indivior said it expects to witness stronger growth in the second half after the easing of Omicron coronavirus restrictions and Covid-19 staff shortages in the healthcare industry.

Indivior forecasts that total sales will rise about 10% to between $840m and $900m while adjusted operating income is expected to be roughly flat year-on-year, at about $187m. 

Ncondezi Energy (NCCL) shares see some light relief jumping 35.00% to 0.675p

Shares in the African power development company saw some light relief on Wednesday morning despite the stock having shed more than 90% in total value since February 2021. 

Despite having no news out, shares ticked up to 0.7p for the first time this month. The company is currently awaiting further clarity on China’s position relating to financing coal projects abroad before progressing with the Tete, Mozambique power project tariff.

The availability of Chinese financing for coal-power projects abroad is considered critical for the project. Ncondezi said it is ready to proceed with the tariff once this has been addressed.

Addressing shareholders last month, Ncondezi’s Chief Executive, Hanno Pengilly said: “We understand this to be a global issue affecting all Chinese backed coal power development projects abroad, and that this impact is under review by the relevant Chinese authorities.”

MYSALE (MYSL) shares rise 33.64% to 2.73p as merchandise value increases by 36%

In a trading update, the online retailer said gross merchandise value had increased 36% to A$86.7m in 1H22 compared to $63.8 in 1H21, reflecting the progress in scaling the Group’s off-price marketplace platform which is expected to become its largest sales channel to date.

As a result of the changing sales mix and growth of the marketplace channel, total revenues declined by 6% to $59.7m, down from $63.8m reported in 1H21, the company highlighted.

Gross profit was A$24.9m, up from A$24.1m 1H21) while gross margins improved to 41.8%, an increase of 370 basis points from 38.1% in 1H21. However, supply chain volatility in 2Q impacted on broader profitability, with Underlying EBITDA at A$1.0m, down from $2.5m.

Global Petroleum (GBP) shares rise 15.79% to 0.88p following publication of work plan

On Monday, Global Petroleum confirmed to investors that a Hydrocarbon Plan for future exploration and development in Italy has been published and has come into legal effect. 
Last month, the European Court had found, in effect, that the Gloval’s four Permit Applications (‘Permit Applications’) offshore Italy in the Southern Adriatic did not contravene EU law.

At the time, Global was advised that the commission appointed by the Government in parallel with the moratorium had completed its deliberations and that the Hydrocarbon Plan for future exploration and development (known in italian as PITESAI) would be published shortly.

Today, Global said it will undertake a detailed study of the Hydrocarbon Plan with its advisors with particular reference to the Company’s four permit applications in the Southern Adriatic.Message Fran